-
Hester Biosciences' Q3 revenue grows 24%
Revenue from operations increased to Rs 148.3 crore in Q3FY23 from Rs 119.8 crore in the corresponding period last year.
-
Hester Biosciences hits 52-week high on strong Q3 results
The stock of Hester Biosciences hit a 52-week high of Rs 2,695.95 on Tuesday, February 14, 2023, after the company reported strong results for the third quarter (Q3) of the financial year 2022-23 (FY23).
-
Hester Biosciences to invest Rs 100 crore in new facility
The new facility will be located in Ahmedabad, Gujarat, and will produce a range of veterinary vaccines and pharmaceuticals.
-
Hester Biosciences' GPS-tracker based poultry solution to be deployed in Tamil Nadu
Hester Biosciences Limited, India's leading poultry vaccine producer, announced the deployment of its innovative GPS-tracker based poultry solution in the state of Tamil Nadu. This solution aims to enhance biosecurity and prevent the spread of poultry diseases, thereby supporting the growth and sustainability of the poultry industry in the state.
-
Hester Biosciences strengthens R&D capabilities with new state-of-the-art facility
Hester Biosciences Limited, India's leading poultry vaccine producer, has inaugurated its new state-of-the-art Research and Development (R&D) facility in Ahmedabad, Gujarat. The new facility will significantly enhance the company's R&D capabilities and support the development of innovative vaccines and solutions for the poultry industry.
-
Hester Biosciences records strong financial performance in Q3 FY23
Hester Biosciences Limited, India's leading poultry vaccine producer, has announced its financial results for the third quarter (Q3) of the financial year 2022-23 (FY23). The company reported strong growth in revenue and profitability, driven by increased demand for its poultry vaccines and other products.